BF Biosciences Limited (PSX:BFBIO)

BF Biosciences Balance Sheet

Financials in millions PKR. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	344.47	278.77	255.44	211.67	421.69
Short-Term Investments	-	-	147.39	1,498	848.82
Trading Asset Securities	1,167	39.01	-	-	-
Cash & Short-Term Investments	1,511	317.78	402.83	1,710	1,271
Cash Growth	375.55%	-21.11%	-76.44%	34.58%	139.20%
Accounts Receivable	184.24	204.61	93.81	52.71	202.49
Other Receivables	45.51	49.33	49.64	-	-
Receivables	229.75	253.94	143.45	67.93	230.01
Inventory	1,740	893.81	852.24	406.55	356.16
Prepaid Expenses	5.34	5.88	2.28	-	-
Other Current Assets	349.88	205.26	190.5	110.93	98.97
Total Current Assets	3,836	1,677	1,591	2,295	1,956
Property, Plant & Equipment	4,306	4,175	4,070	2,135	1,034
Other Intangible Assets	3.98	0.55	1.11	-	-
Other Long-Term Assets	11.85	7.83	4.83	4.83	4.83
Total Assets	8,159	5,860	5,667	4,435	2,995
Accounts Payable	321.12	269.06	225.38	394.28	401.74
Accrued Expenses	541.51	266.09	144.7	13.82	6.74
Short-Term Debt	29.36	328.7	473.39	149.35	-
Current Portion of Long-Term Debt	328.05	292.72	356.88	57.65	16.32
Current Unearned Revenue	134.26	150.87	135.59	99.86	41.6
Other Current Liabilities	269.97	121.15	67.02	-	-
Total Current Liabilities	1,624	1,429	1,403	714.96	466.4
Long-Term Debt	1,367	1,591	1,772	1,537	873.06
Long-Term Unearned Revenue	318.37	432.6	503.73	331.33	172.67
Long-Term Deferred Tax Liabilities	186.58	48.31	13.51	26.55	15.99
Total Liabilities	3,497	3,500	3,693	2,610	1,528
Common Stock	265	190	190	190	190
Additional Paid-In Capital	1,780	-	-	-	-
Retained Earnings	2,617	2,170	1,784	1,502	1,200
Comprehensive Income & Other	-	-	-	132.7	76.27
Shareholders' Equity	4,662	2,360	1,974	1,825	1,467
Total Liabilities & Equity	8,159	5,860	5,667	4,435	2,995
Total Debt	1,725	2,212	2,603	1,744	889.38
Net Cash (Debt)	-213.54	-1,894	-2,200	-34.26	381.13
Net Cash Growth	-	-	-	-	-27.32%
Net Cash Per Share	-2.64	-29.91	-34.74	-0.54	6.02
Filing Date Shares Outstanding	88.33	63.33	63.33	63.33	63.33
Total Common Shares Outstanding	88.33	63.33	63.33	63.33	63.33
Working Capital	2,212	248.08	188.34	1,580	1,489
Book Value Per Share	52.78	37.26	31.17	28.82	23.16
Tangible Book Value	4,658	2,359	1,973	1,825	1,467
Tangible Book Value Per Share	52.73	37.25	31.15	28.82	23.16
Land	25.36	25.36	25.36	-	-
Buildings	993.57	236.06	214.16	-	-
Machinery	4,131	1,191	708.94	-	-
Construction In Progress	133.03	3,516	3,884	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.